AR009673A1 - Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen - Google Patents

Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen

Info

Publication number
AR009673A1
AR009673A1 ARP970106030A ARP970106030A AR009673A1 AR 009673 A1 AR009673 A1 AR 009673A1 AR P970106030 A ARP970106030 A AR P970106030A AR P970106030 A ARP970106030 A AR P970106030A AR 009673 A1 AR009673 A1 AR 009673A1
Authority
AR
Argentina
Prior art keywords
contain
pharmaceutical compositions
trifluorometilfenil
tetrahidropiridina
naftil
Prior art date
Application number
ARP970106030A
Other languages
English (en)
Spanish (es)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR009673A1 publication Critical patent/AR009673A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP970106030A 1996-12-23 1997-12-19 Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen AR009673A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (1)

Publication Number Publication Date
AR009673A1 true AR009673A1 (es) 2000-04-26

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970106030A AR009673A1 (es) 1996-12-23 1997-12-19 Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen

Country Status (37)

Country Link
US (4) US20020028247A1 (OSRAM)
EP (1) EP0950051B1 (OSRAM)
JP (2) JP4422214B2 (OSRAM)
KR (1) KR100455797B1 (OSRAM)
CN (1) CN1088698C (OSRAM)
AR (1) AR009673A1 (OSRAM)
AT (1) ATE250032T1 (OSRAM)
AU (1) AU730302B2 (OSRAM)
BR (1) BR9714177A (OSRAM)
CA (1) CA2275593C (OSRAM)
CO (1) CO4920213A1 (OSRAM)
CZ (1) CZ294272B6 (OSRAM)
DE (1) DE69724999T2 (OSRAM)
DK (1) DK0950051T3 (OSRAM)
DZ (1) DZ2386A1 (OSRAM)
EE (1) EE04112B1 (OSRAM)
EG (1) EG24749A (OSRAM)
ES (1) ES2207758T3 (OSRAM)
FR (1) FR2757510B1 (OSRAM)
HU (1) HU224348B1 (OSRAM)
IL (1) IL129937A (OSRAM)
IN (1) IN186977B (OSRAM)
IS (1) IS2064B (OSRAM)
MY (1) MY126298A (OSRAM)
NO (1) NO311569B1 (OSRAM)
NZ (1) NZ336129A (OSRAM)
PL (1) PL190098B1 (OSRAM)
PT (1) PT950051E (OSRAM)
RU (1) RU2193031C2 (OSRAM)
SI (1) SI0950051T1 (OSRAM)
SK (1) SK283917B6 (OSRAM)
TR (1) TR199901362T2 (OSRAM)
TW (1) TW534820B (OSRAM)
UA (1) UA66776C2 (OSRAM)
WO (1) WO1998028272A1 (OSRAM)
YU (1) YU49427B (OSRAM)
ZA (1) ZA9711579B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2739852T3 (es) * 2001-07-06 2020-02-04 Veloxis Pharmaceuticals As Aglomeración controlada
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
DK0625069T3 (da) * 1992-10-26 1999-08-30 Sanol Arznei Schwarz Gmbh Fremgangsmåde til fremstilling af mikrokapsler
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
HK1024000A1 (en) 2000-09-29
IL129937A0 (en) 2000-02-29
IL129937A (en) 2002-09-12
YU28899A (sh) 2000-03-21
CN1088698C (zh) 2002-08-07
HUP0001181A2 (hu) 2000-11-28
TR199901362T2 (xx) 1999-09-21
HUP0001181A3 (en) 2003-03-28
KR20000069503A (ko) 2000-11-25
DE69724999T2 (de) 2004-07-22
PL190098B1 (pl) 2005-10-31
KR100455797B1 (ko) 2004-11-06
IN186977B (OSRAM) 2001-12-22
RU2193031C2 (ru) 2002-11-20
PL334276A1 (en) 2000-02-14
US20020028247A1 (en) 2002-03-07
EE9900263A (et) 2000-02-15
US20100021541A1 (en) 2010-01-28
CZ294272B6 (cs) 2004-11-10
CZ229199A3 (cs) 1999-09-15
DZ2386A1 (fr) 2002-12-28
US20020192292A1 (en) 2002-12-19
CA2275593A1 (en) 1998-07-02
YU49427B (sh) 2006-01-16
DE69724999D1 (de) 2003-10-23
CN1241179A (zh) 2000-01-12
AU5668598A (en) 1998-07-17
NO993077D0 (no) 1999-06-22
JP2009280581A (ja) 2009-12-03
EE04112B1 (et) 2003-08-15
CO4920213A1 (es) 2000-05-29
SK283917B6 (sk) 2004-05-04
DK0950051T3 (da) 2004-01-26
WO1998028272A1 (fr) 1998-07-02
NO311569B1 (no) 2001-12-10
JP2001507013A (ja) 2001-05-29
IS2064B (is) 2005-11-15
ATE250032T1 (de) 2003-10-15
JP4422214B2 (ja) 2010-02-24
EP0950051A1 (fr) 1999-10-20
PT950051E (pt) 2004-02-27
US20080255365A1 (en) 2008-10-16
EP0950051B1 (fr) 2003-09-17
SI0950051T1 (en) 2004-02-29
BR9714177A (pt) 2000-02-29
NO993077L (no) 1999-06-22
NZ336129A (en) 2000-11-24
CA2275593C (en) 2005-12-20
FR2757510A1 (fr) 1998-06-26
TW534820B (en) 2003-06-01
MY126298A (en) 2006-09-29
FR2757510B1 (fr) 2000-01-07
IS5077A (is) 1999-06-10
SK82999A3 (en) 1999-12-10
AU730302B2 (en) 2001-03-01
EG24749A (en) 2010-07-20
ZA9711579B (en) 1998-06-25
UA66776C2 (uk) 2004-06-15
ES2207758T3 (es) 2004-06-01
HU224348B1 (hu) 2005-08-29

Similar Documents

Publication Publication Date Title
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
AR056635A2 (es) Conjunto de desgaste y elemento de desgaste para una excavadora
AR098808A2 (es) Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
CY1108547T1 (el) Αναλογα σωματοστατινης
ECSP045239A (es) Composicion de ziprasidona y controles sinteticos
AU2003293405A8 (en) Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
ES2178709T3 (es) Pastillas detergentes.
FR2902974B1 (fr) Inhibiteur d'endo-beta-1,4-xylanase et xylanases nouvelles, et produits alimentaires les contenant
EA200400280A1 (ru) Новые неочищенные и кристаллические формы гидрохлорида лерканидипина
SV2002000227A (es) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-isobutiramida caso 20502
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
AR009673A1 (es) Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen
WO2004046293A3 (en) Amphoteric fluorescent whitening agents
AU2002357604A1 (en) Eye drops
MXPA05013509A (es) Polipeptidos de fusion de variante ib alfa de glucoproteina de plaquetas y metodos y uso de los mismos.
ATE212826T1 (de) Desodorierende zubereitungen mit einem gehalt an chitosan, aluminiumchlorhydrat und esteraseinhibitoren
GT199800009A (es) Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3-trifluoro-metilfenil)-1,2,3,6-tetrahidropiridina.
BR9910696A (pt) Composições farmacêuticas
ATE282417T1 (de) Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
UY25247A1 (es) Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer
DK1315700T3 (da) Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner
ATE282416T1 (de) Die verwendung von nk-1 rezeptor antagonisten für die behandlung von substanz-verwendung störungen
AU2002210486A1 (en) Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
WO2002089740A3 (en) Sulfonamides

Legal Events

Date Code Title Description
FC Refusal